The Library

Bipyrimidine ruthenium(II) arene complexes : structure, reactivity and cytotoxicity

Tools

Betanzos-Lara, Soledad, Novakova, Olga, Deeth, Robert J., Pizarro, Ana M., Clarkson, Guy J., Liskova, Barbora, Brabec, Viktor, Sadler, P. J. and Habtemariam, Abraha. (2012) Bipyrimidine ruthenium(II) arene complexes : structure, reactivity and cytotoxicity. JBIC Journal of Biological Inorganic Chemistry, Vol.17 (No.7). pp. 1033-1051. ISSN 0949-8257

Text
WRAP_Deeth_493_JBIC-12-03-00054_Revised Main Script.pdf - Accepted Version
Restricted to Repository staff only until October 2013.
Download (2134Kb)

Official URL: http://dx.doi.org/10.1007/s00775-012-0917-9

Abstract

The synthesis and characterization of complexes [(η6-arene)Ru(N,N′)X][PF6], where arene is para-cymene (p-cym), biphenyl (bip), ethyl benzoate (etb), hexamethylbenzene (hmb), indane (ind) or 1,2,3,4-tetrahydronaphthalene (thn), N,N′ is 2,2′-bipyrimidine (bpm) and X is Cl, Br or I, are reported, including the X-ray crystal structures of [(η6-p-cym)Ru(bpm)I][PF6], [(η6-bip)Ru(bpm)Cl][PF6], [(η6-bip)Ru(bpm)I][PF6] and [(η6-etb)Ru(bpm)Cl][PF6]. Complexes in which N,N′ is 1,10-phenanthroline (phen), 1,10-phenanthroline-5,6-dione or 4,7-diphenyl-1,10-phenanthroline (bathophen) were studied for comparison. The RuII arene complexes undergo ligand-exchange reactions in aqueous solution at 310 K; their half-lives for hydrolysis range from 14 to 715 min. Density functional theory calculations on [(η6-p-cym)Ru(bpm)Cl][PF6], [(η6-p-cym)Ru(bpm)Br][PF6], [(η6-p-cym)Ru(bpm)I][PF6], [(η6-bip)Ru(bpm)Cl][PF6], [(η6-bip)Ru(bpm)Br][PF6] and [(η6-bip)Ru(bpm)I][PF6] suggest that aquation occurs via an associative pathway and that the reaction is thermodynamically favourable when the leaving ligand is I > Br ≈ Cl. pK a* values for the aqua adducts of the complexes range from 6.9 to 7.32. A binding preference for 9-ethylguanine (9-EtG) compared with 9-ethyladenine (9-EtA) was observed for [(η6-p-cym)Ru(bpm)Cl][PF6], [(η6-hmb)Ru(bpm)Cl]+, [(η6-ind)Ru(bpm)Cl]+, [(η6-thn)Ru(bpm)Cl]+, [(η6-p-cym)Ru(phen)Cl]+ and [(η6-p-cym)Ru(bathophen)Cl]+ in aqueous solution at 310 K. The X-ray crystal structure of the guanine complex [(η6-p-cym)Ru(bpm)(9-EtG-N7)][PF6]2 shows multiple hydrogen bonding. Density functional theory calculations show that the 9-EtG adducts of all complexes are thermodynamically preferred compared with those of 9-EtA. However, the bmp complexes are inactive towards A2780 human ovarian cancer cells. Calf thymus DNA interactions for [(η6-p-cym)Ru(bpm)Cl][PF6] and [(η6-p-cym)Ru(phen)Cl][PF6] consist of weak coordinative, intercalative and monofunctional coordination. Binding to biomolecules such as glutathione may play a role in deactivating the bpm complexes.

Item Type:	Journal Article
Subjects:	Q Science > QD Chemistry R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions:	Faculty of Science > Chemistry
Library of Congress Subject Headings (LCSH):	Ruthenium, Aromatic compounds, Hydrolysis, Organometallic compounds -- Therapeutic use, Cell-mediated cytotoxicity, Cisplatin, DNA-ligand interactions
Journal or Publication Title:	JBIC Journal of Biological Inorganic Chemistry
Publisher:	Springer
ISSN:	0949-8257
Date:	October 2012
Volume:	Vol.17
Number:	No.7
Page Range:	pp. 1033-1051
Identification Number:	10.1007/s00775-012-0917-9
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Funder:	Overseas Research Students Awards Scheme (ORSAS), University of Warwick Postgraduate Research Scholarship, Grantová agentura České republiky [Grant Agency of the Czech Republic] (GACR), Consejo Nacional de Ciencia y Tecnología (Mexico) [Mexican Council for Science and Technology] (CONACYT), European Regional Development Fund (ERDF), Advantage West Midlands (AWM), European Research Council (ERC)
Grant number:	P301/10/0598 (GACR), 301/09/H004 (GACR), 247450 (ERC)
References:	1. Jung Y, Lippard SJ (2007) Chem Rev 107:1387–1407. 2. van Zutphen S, Reedijk J (2005) Coord Chem Rev 249:2845–2853. 3. Pizarro AM, Habtemariam A, Sadler PJ (2010) Top Organomet Chem 32:21–56. 4. Aird RE, Cummings J, Ritchie AA, Muir M, Morris RE, Chen H, Sadler, PJ, Jodrell DI (2001) Br J Cancer 86:1652–1657. 5. Yan YK, Melchart M, Habtemariam A, Sadler PJ (2005) Chem. Commun 4764–4776. 6. (a) Fernández R, Melchart M, Habtemariam A, Parsons S, Sadler PJ (2004) Chem Eur J 10:5173–5179; (b) Wang F, Habtemariam A, van der Geer EPL, Fernández R, Melchart M, Deeth RJ, Aird R, Guichard S, Fabbiani FPA, Lozano-Casal P, Oswald IDH, Jodrell DI, Parsons S, Sadler PJ (2005) Proc Natl Acad Sci USA 102:18269–18274. 7. Bloemink MJ, Engelking H, Karentzopoulos S, Krebs B, Reedijk J (1996) Inorg Chem 35:619–627. 8. Nováková O, Kasparkova J, Vrana O, van Vliet PM, Reedijk J, Brabec V (1995) Biochemistry 34:12369–12378. 9. Velders AH, Kooijman H, Spek AL, Haasnoot JG, De Vos D, Reedijk J (2000) Inorg Chem 39:2966-2967. 10. (a) Ishikawa T, Ali-Osman F (1993) J Biol Chem 268:20116–20125; (b) Chen Y, Guo Z, Parkinson JA, Sadler PJ (1998) J Chem Soc Dalton Trans 3577–3585; (c) Teuben J.-M, Reedijk J (2000) J Biol Inorg Chem 5:463–468. 11. Corazza A, Harvey I, Sadler PJ (1996) Eur J Biochem 236:697−705. 12. Buttke TM, Sandstrom PA (1994) Immunol Today 15:7–10. 13. Clarke MJ (2002) Coord Chem Rev 232:69–93. 14. (a) Bennet MA, Smith AK (1974) J Chem Soc Dalton Trans 233–241; (b) Govindaswamy P, Canivet J, Therrien B, Süss-Fink G, Štĕpnička P, Ludvík J (2007) J Organomet Chem 692:3664–3675; (c) Zelonka RA, Baird MC (1972) J Organomet Chem 35:C43–C46; (d) Melchart M, Habtemariam A, Nováková O, Moggach SA, Fabbiani FPA, Parsons S, Brabec V, Sadler PJ (2007) Inorg Chem 46:8950–8962. 15. Habtemariam A, Betanzos-Lara S, Sadler PJ (2010) Inorg Synth 35:160‒163. 16. Brabec V, Palecek E (1970) Biophysik 6:290−300 17. Brabec V, Palecek E (1976) Biophys Chem 4:79−92. 18. Sheldrick GM SHELXL97, University of Göttingen, Germany, 1997. 19. (a) Sheldrick GM (1990) Acta Cryst A46:467−473; (b) Sheldrick GM (2008) Acta Cryst 64:12−122. 20. Krezel A, Bal W (2004) J Inorg Biochem 98:161–166. 21. (a) Te Velde G, Bickelhaupt FM, Baerends EJ, Fonseca Guerra C, Van Gisbergen SJA, Snijders JG, Ziegler T (2001) J Comp Chem 22:931–967; (b) Baerends EJ, Berces A, Bo C, Boerrigter PM, Cavallo L, Deng L, Dickson RM, Ellis DE, Fan L, Fischer TH et. al. (2000) ADF 2009 (Free University, Amsterdam). 22. (a) Wert C, Zener C (1949) Phys Rev 76:1169–1175; (b) Vineyard GH (1957) J Phys Chem Solids 3:121–127. 23. (a) Brabec V, Leng M (1993) Proc Natl Acad Sci USA 90:5345–5349; (b) Lemaire MA, Schwartz A, Rahmouni AR, Leng M (1991) Proc Natl Acad Sci USA 88:1982–1985. 24. Keck MV, Lippard SJ (1992) J Am Chem Soc 114:3386–3390. 25. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) J Nat Cancer Inst 82:1107–1112. 26. (a) Morris RE, Aird RE, del Socorro Murdoch P, Chen H, Cummings J, Hughes ND, Parsons S, Parkin A, Boyd G, Jodrell DI, Sadler PJ (2001) J Med Chem 44:3616−3621; (b) Chen H, Parkinson JA, Parsons S, Coxall RA, Gould RO, Sadler PJ (2002) J Am Chem Soc 124:3064–3082. 27. (a) Süss-Fink G (2010) Dalton Trans 39:1673–1688; (b) Singh A, Chandra M, Sahay AN, Pandey DS, Pandey KK, Mobin SM, Puerta MC, Valerga P (2004) J Organomet Chem 689:1821–1834. 28. Flower KR, Pritchard RG (2001) J Organomet Chem 620:60–68. 29. Gül N, Nelson JH (1999) Organometallics 18:709–725. 30. Gül N, Nelson JH (1999) Polyhedron 18:1835–1843. 31. Bugarcic T, Habtemariam A, Stepankova J, Heringova P, Kašpárková J, Deeth RJ, Johnstone RDL, Prescimone A, Parkin A, Parsons S, Brabec V, Sadler PJ (2008) Inorg Chem 47:11470–11486. 32. (a) van Rijt SH, Hebden AJ, Amaresekera T, Deeth RJ, Clarkson GJ, Parsons S, McGowan P, Sadler PJ (2009) J Med Chem 52:7753–7764; (b) Bugarcic T, Nováková O, Halámiková A, Zerzánková L, Vrána O, Kašpárková J, Habtemariam A, Parsons S, Sadler PJ, Brabec V (2008) J Med Chem 51:5310–5319. 33. Brandl M, Weiss MS, Jabs A, Suhnel J, Hilgenfeld R (2001) J Mol Biol 307:357–377. 34. Bogdanovic GA, Spasojevic-de Bire A, Zaric SD (2002) Eur J Inorg Chem 1599–1602. 35. (a) Dieter-Wurm I, Sabat M, Lippert B (1992) J Am Chem Soc 114:357–359; (b) Witkowshi H, Freisinger E, Lippert B (1997) J Chem Soc Chem Commun 1315–1316; (c) Sigel RKO, Freisinger E, Metzger S, Lippert B (1998) J Am Chem Soc 120:12000–12007. 36. Qu X, Chaires JB (2001) J Am Chem Soc 123:1–7. 37. Betanzos-Lara S, Salassa L, Habtemariam A, Sadler PJ (2009) Chem Commun 6622–6624. 38. Wang F, Chen H, Parsons S, Oswald IDH, Davidson JE, Sadler PJ (2003) Chem Eur J 9:5810–5820. 39. Kunkely H, Vogler A (2003) Inorg Chim Acta 343:357–360. 40. Dadci L, Elias H, Frey U, Hornig A, Koelle U, Merbach AE, Paulus H, Schneider JS (1995) Inorg Chem 34, 306–315. 41. Koefod RS, Mann KR (1990) J Am Chem Soc 112:7287–7293. 42. Dougan SJ, Melchart M, Habtemariam A, Parsons S, Sadler PJ (2007) Inorg Chem 46:10882–10894. 43. Rapaport I, Helm L, Merbach AE, Bernhard P, Ludi A (1988) Inorg Chem 27:873–879. 44. Broomhead JA, Basolo F, Pearson RG (1964) Inorg Chem 3:826–832. 45. Takeuchi KJ, Thompson MS, Pipes DW, Meyer TJ (1984) Inorg Chem 23:1845−1851. 46. (a) Basolo F, Pearson RG Mechanisms of Inorganic Reactions: A Study of Metal Complexes in Solution, Wiley, New York, 2nd Ed., 1967, p 124; (b) Broomhead JA, Kane-Maguire LAP (1968) Inorg Chem 7:2519–2523. 47. Scheller KH, Scheller-Krattiger V, Martin RB (1981) J Am Chem Soc 103:6833–6839. 48. Peacock AFA, Habtemariam A, Fernández R, Walland V, Fabbiani Francesca PA, Parsons S, Aird RE, Duncan IJ, Sadler PJ (2006) J Am Chem Soc 128:1739–1748. 49. Baik M-H, Friesner RA, Lippard SJ (2003) J Am Chem Soc 125:14082–14092. 50. Summa N, Schiessl W, Puchta R, van Eikema Hommes N, van Eldik R (2006) Inorg. Chem. 45: 2948–2959 51. Bancroft DP, Lepre CA, Lippard SJ (1990) J Am Chem Soc 112:6860–6871. 52. (a) Aird R, Cummings J, Ritchie A, Muir M, Morris R, Chen H, Sadler PJ, Jodrell D (2002) Br J Cancer 86:1652–1657; (b) Nováková O, Kasparkova J, Bursova V, Hofr C, Vojtiskova M, Chen H, Sadler PJ, Brabec V(2005) Chem Biol 12:121–129. 53. (a) Ivanov VI, Minchenkova LE, Minyat EE, Frank-Kamenetskii MD, Schyolkina AK (1974) J Mol Biol 87:817‒833; (b) Vorlickova M (1995) Biophys J 69:2033‒2043. 54. Keck MV, Lippard SJ (1992) J Am Chem Soc 114:3386–3390. 55. (a) Richards AD, Rodger A (2007) Chem Soc Rev 36:471−483; (b) Coggan DZM, Haworth IS, Bates PJ, Robinson A, Rodger A (1999) Inorg Chem 38:4486−4497; (c) Nováková O, Chen H, Vrana O, Rodger A, Sadler PJ, Brabec V (2003) Biochemistry 42:11544−11554; (d) Lincoln P, Broo A, Norden B (1996) J Am Chem Soc 118:2644−2653. 56. Habtemariam A, Melchart M, Fernández R, Parsons S, Oswald IDH, Parkin A, Fabbiani FPA, Davidson JE, Dawson A, Aird RE, Jodrell DI, Sadler PJ (2006) J Med Chem 49:6858–6868. 57. Liu HK, Berners-Price SJ, Wang FY, Parkinson JA, Xu JJ, Bella J, Sadler PJ (2006) Angew Chem Int Ed 45:8153–8156.
URI:	http://wrap.warwick.ac.uk/id/eprint/52265